The incidence of urea cycle disorders. 2013

Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
Division of Genetics and Metabolism, Children's National Medical Center, 111 Michigan Ave. NW, Washington DC 20008, USA. msummar@childrensnational.org

A key question for urea cycle disorders is their incidence. In the United States two UCDs, argininosuccinic synthetase and lyase deficiency, are currently detected by newborn screening. We used newborn screening data on over 6million births and data from the large US and European longitudinal registries to determine how common these conditions are. The incidence for the United States is predicted to be 1 urea cycle disorder patient for every 35,000 births presenting about 113 new patients per year across all age groups.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D005060 Europe The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN. Northern Europe,Southern Europe,Western Europe
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000592 Amino Acid Metabolism, Inborn Errors Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (e.g., ACIDOSIS) and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life. Amino Acidopathies, Congenital,Amino Acid Metabolism Disorders, Inborn,Amino Acid Metabolism, Inborn Error,Amino Acid Metabolism, Inherited Disorders,Amino Acidopathies, Inborn,Congenital Amino Acidopathies,Inborn Errors, Amino Acid Metabolism,Inherited Errors of Amino Acid Metabolism,Amino Acidopathy, Congenital,Amino Acidopathy, Inborn,Congenital Amino Acidopathy,Inborn Amino Acidopathies,Inborn Amino Acidopathy
D001123 Argininosuccinate Lyase An enzyme of the urea cycle which splits argininosuccinate to fumarate plus arginine. Its absence leads to the metabolic disease ARGININOSUCCINIC ACIDURIA in man. EC 4.3.2.1. Argininosuccinase,Lyase, Argininosuccinate
D001124 Argininosuccinate Synthase An enzyme of the urea cycle that catalyzes the formation of argininosuccinic acid from citrulline and aspartic acid in the presence of ATP. Absence or deficiency of this enzyme causes the metabolic disease CITRULLINEMIA in humans. EC 6.3.4.5. Argininosuccinate Synthetase,Synthase, Argininosuccinate,Synthetase, Argininosuccinate
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015997 Neonatal Screening The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic. Infant, Newborn, Screening,Newborn Infant Screening,Newborn Screening,Neonatal Screenings,Newborn Infant Screenings,Newborn Screenings,Screening, Neonatal,Screening, Newborn,Screening, Newborn Infant,Screenings, Neonatal,Screenings, Newborn,Screenings, Newborn Infant

Related Publications

Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
July 2014, Seminars in neurology,
Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
July 2003, Current treatment options in neurology,
Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
January 1995, Ryoikibetsu shokogun shirizu,
Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
November 2000, Clinics in liver disease,
Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
February 2002, Seminars in neonatology : SN,
Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
January 2000, Ryoikibetsu shokogun shirizu,
Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
October 1985, Hospital practice (Office ed.),
Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
September 2019, Journal of human genetics,
Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
January 1987, Enzyme,
Marshall L Summar, and Stefan Koelker, and Debra Freedenberg, and Cynthia Le Mons, and Johannes Haberle, and Hye-Seung Lee, and Brian Kirmse, and , and
January 1987, Enzyme,
Copied contents to your clipboard!